A. Klibanski

Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

P. Chanson, A. Mamelak, R. Fahlbusch, 2017, Pituitary.

Clinical practice. Prolactinomas.

A. Klibanski, A. Klibanski, 2010, The New England journal of medicine.

Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Octreotide as Primary Therapy for Acromegaly*

D. Torigian, W. Young, W. Malarkey, 2022 .

Current treatment guidelines for acromegaly.

S. Melmed, A. Klibanski, D. Kleinberg, 1998, The Journal of clinical endocrinology and metabolism.

Octreotide as primary therapy for acromegaly

S. Melmed, M. Molitch, D. Kleinberg, 1998 .

Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro.

A. Klibanski, B. Swearingen, N. Zervas, 1991, The Journal of clinical endocrinology and metabolism.

Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502.

M. Vance, A. Klibanski, M. Molitch, 1990, Annals of internal medicine.

Immune modulation in humans: implications for type 1 diabetes mellitus

S. Melmed, A. Klibanski, C. Strasburger, 2014, Nature Reviews Endocrinology.